News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
328,703 Results
Type
Article (19662)
Company Profile (139)
Press Release (308902)
Section
Business (105207)
Career Advice (872)
Deals (18498)
Drug Delivery (93)
Drug Development (50662)
Employer Resources (79)
FDA (7638)
Job Trends (7719)
News (185551)
Policy (17300)
Tag
Academia (726)
Alliances (27739)
Alzheimer's disease (579)
Approvals (7626)
Artificial intelligence (87)
Bankruptcy (170)
Best Places to Work (5528)
Biosimilars (71)
Breast cancer (81)
Cancer (697)
Cardiovascular disease (68)
Career advice (707)
Cell therapy (105)
Clinical research (42001)
Collaboration (269)
Compensation (89)
COVID-19 (1075)
C-suite (67)
Data (764)
Diabetes (109)
Diagnostics (1722)
Drug pricing (97)
Earnings (38306)
Employer resources (73)
Events (47800)
Executive appointments (253)
FDA (7978)
Funding (191)
Gene therapy (93)
GLP-1 (508)
Government (1802)
Healthcare (5867)
Infectious disease (1128)
Inflammatory bowel disease (72)
Interviews (115)
IPO (7310)
Job creations (2431)
Job search strategy (646)
Layoffs (255)
Legal (4081)
Lung cancer (107)
Lymphoma (65)
Manufacturing (148)
Medical device (1951)
Medtech (1954)
Mergers & acquisitions (11271)
Metabolic disorders (371)
Neuroscience (772)
NextGen Class of 2024 (2347)
Non-profit (903)
Northern California (756)
Obesity (236)
Opinion (177)
Patents (84)
People (33006)
Pharmaceutical (78)
Phase I (13114)
Phase II (17775)
Phase III (14299)
Pipeline (319)
Policy (73)
Postmarket research (1616)
Preclinical (4591)
Radiopharmaceuticals (156)
Rare diseases (166)
Real estate (3164)
Regulatory (12215)
Research institute (816)
Resumes & cover letters (138)
Southern California (698)
Startups (2005)
United States (6930)
Vaccines (216)
Weight loss (199)
Date
Today (67)
Last 7 days (322)
Last 30 days (1204)
Last 365 days (17693)
2024 (17627)
2023 (19637)
2022 (25865)
2021 (26639)
2020 (24871)
2019 (20058)
2018 (15587)
2017 (17253)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (406)
Asia (24552)
Australia (3159)
California (1718)
Canada (839)
China (185)
Colorado (72)
Connecticut (69)
Europe (50653)
Florida (255)
Illinois (176)
Indiana (128)
Japan (66)
Maryland (255)
Massachusetts (1433)
Minnesota (99)
New Jersey (678)
New York (496)
North Carolina (378)
Northern California (756)
Ohio (64)
Pennsylvania (409)
South America (604)
Southern California (698)
Texas (234)
Washington State (158)
328,703 Results for "promore pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Report from the Extraordinary General Meeting of Promore Pharma AB Held on 29 December 2023
Promore Pharma Promore Pharma AB, under change of name to PMD Device Solutions AB, held an extraordinary general meeting on Friday, 29 December 2023.
December 29, 2023
·
3 min read
Policy
Promore Pharma initiates voluntary liquidation
Promore Pharma AB announced that the company has entered into voluntary liquidation and that the Swedish Companies Registration Office has appointed attorney Lars-Henrik Andersson as liquidator.
October 12, 2023
·
3 min read
Notice of Extraordinary General Meeting in Promore Pharma AB (Publ)
The shareholders of Promore Pharma AB, reg. no. 556639-6809, are hereby invited to an extraordinary general meeting on 29 December 2023 at 10:00 am CET at Eversheds Sutherland’s premises at Sveavägen 20, 111 57 Stockholm.
November 29, 2023
·
4 min read
Deals
Promore Pharma AB intends to carry out a reverse acquisition of PMD Device Solutions AB
Promore Pharma AB intends to acquire all the shares in PMD Device Solutions AB by making payment in the form of newly issued shares in the Company.
November 29, 2023
·
12 min read
Promore Pharma Engages Erik Penser Bank as Liquidity Provider
Promore Pharma AB announced that the company has entered into an agreement with Erik Penser Bank to act as liquidity provider for the Promore Pharma share starting 21 August 2023.
August 16, 2023
·
1 min read
Report from the Extraordinary General Meeting of Promore Pharma AB held on 5 October 2023
Promore Pharma AB, reg. no. 556639-6809, held an extraordinary general meeting on Thursday, 5 October 2023.
October 5, 2023
·
2 min read
Notice of Extraordinary General Meeting Promore Pharma AB (Publ)
Promore Pharma AB will hold an Extraordinary General Meeting on Thursday, 5 October 2023 at 10.00 am, in Advokaterna Liman & Partners AB:s premises at Grev Turegatan 38, 114 38 Stockholm.
September 18, 2023
·
6 min read
Promore Pharma’s Annual Report 2022
The 2022 Annual report of Promore Pharma AB is now available on the Company’s website.
May 9, 2023
·
1 min read
Promore Pharma AB (publ) has received approval for continued trading on Nasdaq First North Growth Market and publishes company description
Promore Pharma AB, under name change to PMD Device Solutions AB, has received approval for continued trading on Nasdaq First North Growth Market and publishes a company description prepared in connection with the name and business change of the Company as a result of the planned acquisition of PMD Device Solutions AB.
December 21, 2023
·
2 min read
Report from the Annual General Meeting of Promore Pharma AB held on 27 June 2023
Promore Pharma Promore Pharma AB, reg. no. 556639-6809, held its AGM on Tuesday, 27 June 2023.
June 27, 2023
·
3 min read
1 of 32,871
Next
